Newsroom

Sorted by: Latest

-

Toshiba推出針對車載裝置的光電輸出光耦合器

日本川崎--(BUSINESS WIRE)--(美國商業資訊)-- Toshiba Electronic Devices & Storage Corporation ("Toshiba")推出了一款光電輸出光耦合器「TLX9920」,採用薄型、長爬電距離SO6L封裝,用於車載裝置的固態繼電器(SSR)[1]。批量出貨自即日起開始。 市場對更長壽命車載裝置繼電器單元的需求不斷成長,這一趨勢推動SSR逐步替代機械繼電器。隨著車載系統持續演進,向SSR的轉換可望進一步加快。 TLX9920適合用作SSR中高壓功率MOSFET的閘極驅動器。它在搭配高壓功率MOSFET使用時,可實現光繼電器難以企及的高壓、大電流開關。與機械繼電器不同,SSR無實體觸點,因此不會出現觸點磨損,也無需定期維護。TLX9920還符合車載電子元件可靠性標準AEC-Q101。 該產品採用SO6L封裝,爬電距離超過8mm,實現了高隔離電壓(BVs=5000Vrms)。例如,國際標準IEC 60664-12[2]規定,在污染等級2、工作電壓400V及以上的環境中應用時,爬電距離不得小於5.6mm。TLX9920滿足這...
-

Toshiba推出面向车载设备的光伏输出光电耦合器

日本川崎--(BUSINESS WIRE)--(美国商业资讯)-- Toshiba Electronic Devices & Storage Corporation ("Toshiba")推出了一款光伏输出光电耦合器“TLX9920”,采用薄型、长爬电距离SO6L封装,用于车载设备的固态继电器(SSR)[1]。批量出货自即日起开始。 市场对更长寿命车载设备继电器单元的需求不断增长,这一趋势推动SSR逐步替代机械继电器。随着车载系统持续演进,向SSR的过渡预计将进一步加速。 TLX9920适合用作SSR中高压功率MOSFET的栅极驱动器。它在搭配高压功率MOSFET使用时,可实现光继电器难以实现的高压、大电流开关。与机械继电器不同,SSR无物理触点,因此不会出现触点磨损,也无需定期维护。TLX9920还符合车载电子元件可靠性标准AEC-Q101。 该产品采用SO6L封装,爬电距离超过8mm,实现了高隔离电压(BVs=5000Vrms)。例如,国际标准IEC 60664-12[2]规定,在污染等级2、工作电压400V及以上的环境中应用时,爬电距离需不小于5.6mm。TLX9920满...
-

Vertical Aerospace Launches Battery Pilot Production Line for Valo

LONDON & NEW YORK--(BUSINESS WIRE)--Vertical Aerospace (“Vertical” or “the Company”) (NYSE: EVTL), a global aerospace and technology company pioneering electric aviation, today announced that its battery pilot production line is now operational at its Vertical Energy Centre (VEC). Building on proven battery technology The 15,000 sq ft Vertical Energy Centre opened in 2023 and has produced the battery systems used in the Company’s piloted flight testing since 2024. These proprietary batteries ha...
-

Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026

LOS ANGELES--(BUSINESS WIRE)--Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotechnology company, today announced that its first-in-class approach for treating hair loss with investigational medicine PP405 will be featured in a presentation about advances in the hair loss treatment landscape and regenerative mechanisms on Saturday, March 28th at the American Academy of Dermatology (AAD) Annual Meeting, taking place in Denver, Colorado. Presentation Details: Session: S020 New I...
-

Mirecule Expands Strategic FSHD Collaboration with Sanofi

GAITHERSBURG, Md.--(BUSINESS WIRE)--Mirecule expands strategic collaboration with Sanofi on advancement of best-in-class ARC treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)...
-

General Mills Reports Fiscal 2026 Third-quarter Results and Reaffirms Full-year Outlook

MINNEAPOLIS--(BUSINESS WIRE)--General Mills, Inc. (NYSE: GIS) today reported results for its third quarter ended February 22, 2026. “We’re reaffirming our fiscal 2026 guidance today, as our focus on executing our Remarkability playbook continued to deliver stronger competitiveness for our brands in the third quarter,” said General Mills Chairman and Chief Executive Officer Jeff Harmening. “We started the year expecting that our investments, divestitures, and unfavorable timing comparisons would...
-

Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 25, 2026

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting of shareholders of the Company will be held on Wednesday, March 25, 2026 at 2:00pm Eastern Time in a virtual-only format where shareholders may attend and participate in the meeting via live webcast. The meeting will include a presentation from Covalon’s CEO, Brent Ashton, with a Question and Answ...
-

Palladyne AI Subsidiary Selected by U.S. Navy to Develop Low Cost Near Hypersonic Missile

SALT LAKE CITY--(BUSINESS WIRE)--Palladyne AI Subsidiary Selected by U.S. Navy to Develop Low Cost Near Hypersonic Missile...
-

Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced an oral presentation and multiple poster presentations of five abstracts at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17-22 in San Diego. Presentation Details: Title: Preclinical assessment of BT552...
-

Perfect Announces Receipt of Preliminary Non-Binding “Going Private” Proposal

NEW YORK--(BUSINESS WIRE)--Perfect Corp. (NYSE: PERF) (“Perfect” or the “Company”), a leading artificial intelligence (“AI”) company offering AI and augmented reality (“AR”) powered solutions to beauty, fashion, photo and video creative industries, today announced that its board of directors (the “Board”) has received a preliminary non-binding proposal letter, dated March 18, 2026 (the “Proposal”), from CyberLink International Technology Corp. (“CyberLink”) and Ms. Alice H. Chang, Chairwoman of...